The International Kidney Cancer Coalition (IKCC)’s International Conference 2024 wrapped up its three-day event in Incheon, Korea, on Tuesday. About 60 kidney cancer patient group leaders from 21 countries, medical doctors, and university professors attended.Korea is the first Asian country to host
Studies have shown that high levels of distress at the time of cancer diagnosis are associated with a higher risk of recurrence and death.According to an expert, however, only 10 percent of cancer patients are assessed and diagnosed for psychiatric problems despite the emotional distress they experi
Korean researchers identified the mechanism of brain tumor recurrence through cancer protein genome analysis "for the first time in the world," a local cancer hospital said. The National Cancer Center (NCC) said Wednesday that Dr. Park Jong-bae, head of the Cancer Proteomics Division, and Dr. Kim Ky
"My wife passed away from lung cancer last year. I never thought she would get lung cancer because she was a non-smoker and was so healthy that she hardly caught a cold. She went to her annual check-ups and never missed a chest X-ray, but she lived less than three years after the diagnosis of stage
Parents in Korea and other Asian countries are unusually concerned about their children's height. That is partly because Asians tend to be shorter than people in the West. Still, this interest in height has given rise to the academic term "heightism" in sociology, referring to social prejudice and d
Sleep is a fundamental human right crucial for overall health and well-being, yet it remains elusive for many.However, experts point out that Korean adolescents, truck drivers, shift workers, and women who are raising children do not get enough sleep and need policy support not only from individuals
The government's push to increase the medical school enrollment quota has led to the departure of most medical residents from training hospitals, forcing various medical societies to cancel annual workshops for new interns and residents.Kim Seung-hyun, president of the Korean Neurological Associatio
More than a month has passed since Enhertu (trastuzumab deruxtecan), a new breast cancer drug provided by Daiichi Sankyo Korea and AstraZeneca Korea, passed the Drug Reimbursement Evaluation Committee under the Health Insurance Review and Assessment Service (HIRA).However, news on its reimbursement
Roche Korea hosted a two-day RISE (Roche Initiated Scientific Exchange) symposium on Thursday and Friday last week, shedding light on the clinical significance of the pioneering bispecific antibodies for blood cancer, Columvi (ingredient: glofitamap) and Lunsumio (mosunetuzumab).Comprising five sess
To combat acquired immunodeficiency syndrome (AIDS), the government will focus on preventing new infections of the human immunodeficiency virus (HIV) and drastically improving access to healthcare.As a means of expanding medical access, it will actively detect patients, expand opportunities for self
A new treatment has landed in Korea for moderate to severe active ulcerative colitis that has not responded adequately to standard treatments or biologics or has become unresponsive.Lilly Korea said Thursday that the interleukin-23 (IL-23) inhibitor Omvoh (mirikizumab) has received approval from the
Bayer Korea's treatment for chronic kidney disease with type 2 diabetes, Kerendia (finerenone), will be covered by health insurance for adult patients starting next month.Kerendia is a first-in-class non-steroidal selective antagonist of the mineralocorticoid receptor, a novel mechanism of action th
Ajou University Hospital introduced the radiation therapy equipment, Halcyon 4.0 HyperSight, for the first time in Asia and began full-scale operation on Monday.Halcyon is a state-of-the-art radiotherapy equipment that performs optimal three-dimensional intensity-modulated rotational treatment in re
Patients with severe hemophilia A often have to give up even light physical activities due to joint pain, let alone exercise.However, a recent study has shown that these patients drastically improved their quality of life by reducing the frequency of bleeding and could engage in physical activities
“A patient unresponsive to potent medications such as tumor necrosis factor-alpha inhibitors (TNF-α inhibitors) or interleukin-17A (IL-17A) experienced noteworthy pain relief within a mere week of taking Rinvoq (upadacitinib). This rapid response outpaces the typical two-week timeframe associated wi
BMS Korea’s plaque psoriasis drug Sotyktu (deucravacitinib) has failed to cross the Pharmaceutical Benefits Evaluation Committee threshold, carrying the tag “conditional approval.”The drug won the Ministry of Food and Drug Safety (MFDS)’s approval in August and quickly applied for reimbursement but
Hemophilia is a bleeding disorder caused by a congenital, inherited mutation in a gene on the X chromosome that results in a lack of clotting factors in the blood.The standard treatment for hemophilia is “prophylaxis therapy,” the regular administration of factor 8 concentrates for people with hemop
Turner syndrome is the most common of the sex chromosome abnormalities in women. Women are supposed to have two X chromosomes, but one of them is completely or partially missing in this rare disease. The most common symptom is short stature; the average adult female with Turner syndrome is 143 centi
For the first time in Korea, a study has used a machine learning model to segment leukemia by cytogenetic characteristics and applied it to personalized treatment strategies for elderly acute myeloid leukemia patients.Acute myeloid leukemia is a blood cancer that is increasing as the population ages
Handok’s Vyxeos liposomal Injection, a combination of cytarabine and daunorubicin for therapy-related acute myeloid leukemia (t-AML) and acute myeloid leukemia with myelodysplasia-related change (AML-MRC), has crossed the first threshold for reimbursement in its second attempt.Gilead Sciences’ Trode